Source: Virtual Congress 2021 – Adult cystic fibrosis



Rating:

Share or cite this content

Citations should be made in the following way:
J. Mencarini (Florence, Italy), E. Fiscarelli (Rome, Italy), L. Cariani (Milan, Italy), G. Linardos (Rome, Italy), D. Girelli (Milan, Italy), M. Rossitto (Rome, Italy), S. Pollini (Florence, Italy), A. Teri (Milan, Italy), G. Taccetti (Florence, Italy), A. Bartoloni (Florence, Italy), S. Bresci (Florence, Italy). Aspergillus pulmonary disease in cystic fibrosis (CF) patients: multicentre perspective observational study based on new diagnostic tests to evaluate the prognostic value on the CF disease. 1498

Member's Comments

No comment yet.

Related content which might interest you: The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019 STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Prospective study on clinical and immunological Aspergillus categorization in cystic fibrosis. Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 The value of BAL in the assessment of pulmonary sarcoidosis in clinical practice: a retrospective analysis Source: Eur Respir J 2001; 18: Suppl. 33, 68s Year: 2001 CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response ? A meta-analysis. Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 A contemporary survival analysis of individuals with cystic fibrosis: a cohort study Source: Eur Respir J 2015; 45: 670-679 Year: 2015 Predictive value of spirometry in early detection of obstructive lung disease in adults: a cohort study Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 The concept of cystic fibrosis pulmonary exacerbation in clinical medicine and as a trial end-point Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art Year: 2008 Persistent lung abnormalities versus established fibrosis: a prospective study of COVID-19 follow-up Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021 An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 CIPHER: a prospective, multicentre study for the identification of biomarker signatures for early detection of pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010